Literature DB >> 8050591

Concanamycin A blocks influenza virus entry into cells under acidic conditions.

R Guinea1, L Carrasco.   

Abstract

The selective inhibitor of the vacuolar proton-ATPase, concanamycin A, powerfully blocks influenza virus entry into cells, if present during the initial times of virus infection. Attachment of virus particles to cells is not prevented by concanamycin A, rather the exit of influenza virus from endosomes is the step blocked by this macrolide antibiotic. Inhibition of influenza virus entry into cells by concanamycin A or by nigericin takes place under acidic conditions. Moreover, if the pH gradient is abolished by pre-incubation of cells in acidic pH, influenza virus entry does not occur even in the absence of any inhibitors. These results indicate that acidic conditions per se are not sufficient to promote virus entry into cells; rather this step of virus infection requires a pH gradient.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8050591     DOI: 10.1016/0014-5793(94)00695-4

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  11 in total

Review 1.  Uncovering the global host cell requirements for influenza virus replication via RNAi screening.

Authors:  Silke Stertz; Megan L Shaw
Journal:  Microbes Infect       Date:  2011-01-27       Impact factor: 2.700

2.  The entry of reovirus into L cells is dependent on vacuolar proton-ATPase activity.

Authors:  C G Martínez; R Guinea; J Benavente; L Carrasco
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

3.  Requirement for vacuolar H+ -ATPase activity and Ca2+ gradient during entry of rotavirus into MA104 cells.

Authors:  Maria Elena Chemello; Olga Carolina Aristimuño; Fabián Michelangeli; Marie-Christine Ruiz
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

Review 4.  Autophagy in health and disease: From molecular mechanisms to therapeutic target.

Authors:  Guang Lu; Yu Wang; Yin Shi; Zhe Zhang; Canhua Huang; Weifeng He; Chuang Wang; Han-Ming Shen
Journal:  MedComm (2020)       Date:  2022-07-10

5.  Requirement for vacuolar proton-ATPase activity during entry of influenza virus into cells.

Authors:  R Guinea; L Carrasco
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

Review 6.  Mechanisms of viral entry: sneaking in the front door.

Authors:  Jennifer A Thorley; Jane A McKeating; Joshua Zachary Rappoport
Journal:  Protoplasma       Date:  2010-05-06       Impact factor: 3.356

Review 7.  Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part II: Future compounds against influenza virus.

Authors:  R Gasparini; D Amicizia; P L Lai; N L Bragazzi; D Panatto
Journal:  J Prev Med Hyg       Date:  2014-12

Review 8.  Progress of small molecular inhibitors in the development of anti-influenza virus agents.

Authors:  Xiaoai Wu; Xiuli Wu; Qizheng Sun; Chunhui Zhang; Shengyong Yang; Lin Li; Zhiyun Jia
Journal:  Theranostics       Date:  2017-02-08       Impact factor: 11.556

9.  Role of a Transbilayer pH Gradient in the Membrane Fusion Activity of the Influenza Virus Hemagglutinin: Use of the R18 Assay to Monitor Membrane Merging.

Authors:  João Ramalho-Santos; Maria C. Pedroso De Lima
Journal:  Biol Proced Online       Date:  1999-03-16       Impact factor: 3.244

10.  Host-directed combinatorial RNAi improves inhibition of diverse strains of influenza A virus in human respiratory epithelial cells.

Authors:  Michael A Estrin; Islam T M Hussein; Wendy B Puryear; Anne C Kuan; Stephen C Artim; Jonathan A Runstadler
Journal:  PLoS One       Date:  2018-05-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.